Page last updated: 2024-09-03

lvv-hemorphin-7 and divalinal-angiotensin iv

lvv-hemorphin-7 has been researched along with divalinal-angiotensin iv in 3 studies

Compound Research Comparison

Studies
(lvv-hemorphin-7)
Trials
(lvv-hemorphin-7)
Recent Studies (post-2010)
(lvv-hemorphin-7)
Studies
(divalinal-angiotensin iv)
Trials
(divalinal-angiotensin iv)
Recent Studies (post-2010) (divalinal-angiotensin iv)
590141603

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albiston, AL; Chai, SY; Lew, RA; McDowall, SG; Mustafa, T; Ye, S1
Albiston, AL; Allen, AM; Barrett, GL; Chai, SY; Lee, J; McDowall, SG; Mendelsohn, FA; Morris, MJ; Murphy, M; Ping, SE1
Beyer, CE; Dwyer, JM; Lin, Q; Ling, HP; Luo, B; Mark, RJ; Neal, S; Platt, BJ; Rosenzweig-Lipson, S; Schechter, LE1

Other Studies

3 other study(ies) available for lvv-hemorphin-7 and divalinal-angiotensin iv

ArticleYear
Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
    Journal of neurochemistry, 2003, Volume: 86, Issue:2

    Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Cell Line; Cystinyl Aminopeptidase; Enzyme Activation; Enzyme Inhibitors; Hemoglobins; Humans; Kidney; Leucine; Ligands; Oligopeptides; Peptide Fragments; Peptides; Receptors, Angiotensin; Recombinant Proteins; Substrate Specificity

2003
Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.
    Neuroscience, 2004, Volume: 124, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Avoidance Learning; Behavior, Animal; Hemoglobins; Injections, Intraventricular; Learning; Male; Oligopeptides; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Angiotensin; Spatial Behavior; Time Factors

2004
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.
    Psychopharmacology, 2010, Volume: 209, Issue:4

    Topics: Amygdala; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Exploratory Behavior; Hemoglobins; Immunoassay; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Ligands; Male; Mice; Microdialysis; Oxytocin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Oxytocin; Time Factors; Up-Regulation

2010